Your browser doesn't support javascript.
loading
OVA12 promotes tumor growth by regulating p53 expression in human cancer cells.
Zhang, Renfeng; Wu, Xicai; Xia, Xiangfeng; Khanniche, Asma; Song, Feifei; Zhang, Bingchang; Wang, Ying; Ge, Hailiang.
Afiliación
  • Zhang R; Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Wu X; Clinical Laboratory, People's Hospital of Rizhao, Rizhao, China.
  • Xia X; Department of Radiology, The Third People's Hospital of Rizhao, Rizhao, China.
  • Khanniche A; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Song F; Department of Pathology, Tenth People's Hospital of Tongji University, Shanghai, China.
  • Zhang B; Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Wang Y; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Ge H; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Oncotarget ; 8(32): 52854-52865, 2017 Aug 08.
Article en En | MEDLINE | ID: mdl-28881777
Ovarian cancer-associated antigen 12 (OVA12) was first identified in an ovarian carcinoma complementary DNA (cDNA) expression library and has been shown to play an important role in tumor growth. Here, we found that overexpression of OVA12 accelerated tumor growth in different tumor cells, whereas OVA12 depletion was associated with the opposite effect. Moreover, knocking down OVA12 led to a significant increase in the protein levels of p53, and the overexpression of OVA12 significantly decreased endogenous p53 levels. In addition, OVA12 stimulated p53 polyubiquitination and degradation by the proteasome and promoted tumor growth at least partially through the p53 pathway. Taken together, these results indicate that OVA12 is a negative regulator of p53 and that inhibition of OVA12 expression might serve as a therapeutic target to restore tumor suppression.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos